erlotinib hydrochloride has been researched along with Alloxan Diabetes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Liang, G; Luo, W; Qian, Y; Wang, J; Wang, Y; Xu, Z; Yin, H; Zheng, C; Zhuang, F | 1 |
| Dobrowsky, RT; Pan, P | 1 |
| Harris, RC; Paueksakon, P; Wang, Y; Zhang, MZ | 1 |
| Grabowski, T; Grześkowiak, E; Karbownik, A; Sobańska, K; Szałek, E; Wolc, A | 1 |
| Altintas, MM; Baltimore, D; Bitzer, M; Cimbaluk, DJ; Faridi, MH; Geraghty, T; Grahammer, F; Gupta, V; Huber, TB; Khaliqdina, S; Khan, SQ; Koh, KH; Kretzler, M; Lee, HW; Moita, LF; Reiser, J; Susztak, K; Tardi, NJ; Tharaux, PL; Zhao, JL | 1 |
5 other study(ies) available for erlotinib hydrochloride and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes.
Topics: Aminosalicylic Acids; Animals; Benzenesulfonates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Rats; STAT3 Transcription Factor | 2019 |
Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Down-Regulation; Erlotinib Hydrochloride; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Neural Conduction; Neuregulin-1; Protein Isoforms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Sural Nerve | 2013 |
Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.
Topics: Albuminuria; AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Blood Glucose; Blood Pressure; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Endoplasmic Reticulum Stress; ErbB Receptors; Erlotinib Hydrochloride; Immunohistochemistry; Kidney; Mice; Mice, Inbred NOD; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Signal Transduction | 2014 |
The alteration of pharmacokinetics of erlotinib and OSI420 in type 1 diabetic rabbits.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Deoxycytidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erlotinib Hydrochloride; Female; Gemcitabine; Male; Protein Kinase Inhibitors; Rabbits | 2016 |
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Erlotinib Hydrochloride; Mice; Mice, Knockout; MicroRNAs; Podocytes; Receptor, ErbB-4; Receptor, Notch1; Ribonucleases; Risk Factors; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation | 2017 |